EPISODE 169 | RELEASED May 30, 2022

ELIAS Cancer Immunotherapy for Dogs | Tammie Wahaus

Bone cancer is a brutal disease, but ELIAS Animal Health has an immunotherapy protocol that is making headway.


Immunotherapy is becoming increasingly important in human cancer treatment, and more and more companies are bringing this technology over to dogs! The ELIAS Cancer Immunotherapy (ECI) system is still experimental, but they are already seeing positive results in the approximately 200 dogs that have been treated so far.

CEO Tammie Wahaus explains how ECI works, the role of a healthy immune system in successful immunotherapy, and why they chose to focus on osteosarcoma first. A randomized pivotal trial comparing dogs treated with ECI to dogs treated with carboplatin chemotherapy will be complete later this year, and we will be following those results.

Links Mentioned in Today’s Show:

ELIAS Cancer Immunotherapy

Canine Osteosarcoma Clinical Trial


Hosted By


Did You Find This Helpful? Share It with Your Pack!

Share on social media, download a PDF, print this out, or send this in an email to your veterinarian.


Editor's Picks